ProCE Banner Activity

Key HIV Studies Influencing My Practice Following HIVR4P 2024—Drs. Linda-Gail Bekker and Meredith Clement

Podcast Episodes

Hear from Meredith E. Clement, MD, and Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD, as they discuss their insights on some of the most clinically relevant new data presented at HIVR4P 2024, covering studies on investigational PrEP options and strategies to improve PrEP implementation and uptake.

Released: October 30, 2024

Expiration: October 29, 2025

Share

Faculty

Linda-Gail Bekker

Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD

Director and Professor, The Desmond Tutu HIV Centre, UCT
CEO, The Desmond Tutu Health Foundation
Cape Town, South Africa

Meredith E. Clement

Meredith E. Clement, MD

Associate Professor of Medicine
Section of Infectious Diseases
Louisiana State University Health Sciences Center-New Orleans
New Orleans, Louisiana

Provided by

Provided by Clinical Care Options, LLC in partnership with the International AIDS Society

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS

ProCE Banner

Disclosure

Primary Author

Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD

Director and Professor, The Desmond Tutu HIV Centre, UCT
CEO, The Desmond Tutu Health Foundation
Cape Town, South Africa

Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD: consultant/advisor/speaker: Gilead, Merck PTY LTD, ViiV.

Meredith E. Clement, MD

Associate Professor of Medicine
Section of Infectious Diseases
Louisiana State University Health Sciences Center-New Orleans
New Orleans, Louisiana

Meredith E. Clement, MD: consultant/advisor/speaker: ViiV; researcher: Gilead, ViiV.